Tampilan Imunohistokimia Epidermalgrowth Factor Reseptor (Egfr) Dan B-Cell Leukemia Lymphoma-2 (Bcl-2) Pada Subtipe Histopatologi Karsinoma Sel Basal
69
DAFTAR PUSTAKA
1. Barhnhill RL, Croeson AN, Magro CM, Piepkorn MW. Dermatopathology. 3th
ed. New York:McGraw-Hill Medical; 2010: 578-590. [cited on 2013 Aug 01]
2.
Gawkrodger DJ. Dermatology: An Illustrated Colour Text. 3th ed. London:
Churchill Livingstone; 2002: 2,3,96,97. [cited on 2013 Aug 01]
3.
Tuzun Y, Kutlubay Z, Engin B, serdalogru S. Basal Cell Carcinoma. Turkey:
Istanbul University; 2011: 51-86. [cited 2014 Aug 01]
4.
UCSF Medical Centre. Basal cell and squamous cell carcinoma. San Fransisco;
2014 [cited 2014 Feb 03].
5. Weedon D, Marks R, Kao GF, Harwood CA. Keratinocytic tumours:
Introduction. In : LeBoit, PE, Burg G, Weedon D, Sarasin A. (editors).
Pathology and Genetics of Skin Tumours. World Health Organization
Classification of Tumour. Lyon: IARC Press; 2003: p.11-19.
6.
Flohil SC, Vries ED, Neumann M, Coeberg JW, Nijsten T. Incidence,
Prevalence and Future Trend of Primary Basal Cell Carcinoma in the
Netherland.Acta Derm Venereol.2011; 91: 24-30. [cited 2014 Feb 03]
7. Christenson LJ, Borrowman TA, Vachon CM, Tollefson MM, Otley GC,
Weaver AL, et al. Incidence of Basal Cell and Squamous Cell Carcinomas in a
Population Younger Than 40 Years.JAMA; 2005 Aug 9: 681-90. [cited 2014
Feb 03]
8. Cancer Council Australia. Clinical Practice Guide: Basal-Cell Carcinoma,
Squamous
Cell
Carcinoma
(and
related
lesion)-a
guide
to
clinical
Universitas Sumatera Utara
70
managementinAustralia.[Internet].2008Nov[cited2014Juli03];
http://www.cancer.org.au/content/pdf/HealthProfessionals/ClinicalGuidelines/B
asal_cell_carcinoma_Squamous_cell_carcinoma_Guide_Nov_2008Final_with_Corrigendums.pdf
9. Ricotti C, Bouzari N, Agadi A, Cockerell CJ. Malignant Skin Neoplasms. USA:
Elsevier Inc; 2009 : 1241- 54. [cited 2013 Aug 01]
10. Chinem VP, Miot HA. Epidemiology of Basal Cell Carcinoma. Anais
Brasileiros de Dermatologia. 2011; 86(2):292-305. [cited 2013 Aug 01]
11. Epstein EH. Basal cell carcinomas: Attack of the Hedgehog. USA; Mac Millan
Publisher Limited; 2008: 743-754. [cited 2013 Aug 01]
12. Gu D dan Xie J. Research progress in the cell origin of basal cell
carcinoma.World J Med Genet. Baishideng. 2011; 1(1):11-13. [cited 2013 Aug
01]
13. White GM, dan Cox NH. Malignant and Premalignant Epidermal Neoplasia. In:
Disease of the Skin. W.B. Saunders. USA.2002. [cited 2013 Aug 01]
14. Telfer NR, Colver GB dan Morton CA. Guidelines for the management of basal
carcinoma. British Journal of Dermatology 2008; 159: 35-48. [cited 2013 Aug
01]
15. Wu PA. The Epidemiology of Basal Cell Carcinomas.UpToDate, Inc.
[Internet]. 2014 [cited 2014Feb 03].
16. American Cancer Society. Skin Cancer: Basal and Squamous Cell. American
Cancer Society; 2012: 1-47. [cited 2013 Aug 01] Tersedia di website:
http://www.cancer.org/acs/groups/cid/documents/webcontent/003139-pdf.pdf
Universitas Sumatera Utara
71
17. The
Structure
and
Function
of
the
Skin.[cited
2013
Aug
01].
www.advancedbodyworks.co.uk/docs/skinEssay.pdf.
18. Turner R. Basal Cell Carcinoma. Oxford: Oxford Redcliffe Hospital NHS
Trust; 2011: 1-4. [cited 2014 Aug 01]
19. Oakley A dan Newman P. Cutaneus Tumours. DermNet NZ. New Zealand.
2012: 6. [cited 2014 Aug 01]
20. Hunter J, Savin J, Dahl M. Clinical Dermatology. 3th ed. Oxford: Blackwell
Science Ltd; 2002: 265-67. [cited 2014 Aug 01]
21. Buljan M, Bulat V,Situm M,Mihic LL, Duktaj SS. Variation in Clinical
Presentation of Basal Cell Carcinoma. Croatia: Acta Clin Croat; 2008: 25-30.
[cited 2014 Aug 01]
22. The Skin Cancer Foundation. Basal Cell Carcinoma-Causes and Risk Factors.
New
York.
2013
[cited
2013
Aug
01].
Tersedia
di
website:
http://www.skincancer.org/skin-cancer-information/basal-cell-carcinoma/bcccauses-and-risk-factors
23. Haskell H. Histology of the Skin. In: Busam KJ (editor). Dermatopathology.
USA: Saunders, an imprint of Elsevier Inc; 2010: p.1-4. [cited 2014 Aug 01]
24. Basal cell carcinoma : possible role of some proliferative and apoptotic factors (
cited on 2014,Agustus 12). J Egypt wom Dermatol sac. Vol 6 No.1.2009.
25. Immunohistochemical nuclear staining for p53, PCNA, Ki67, and Bcl-2 in
different histologic variants of basal cell carcinoma.( cited on 2014, Agustus
12), Rom J Morphol Embryonla 2011, 52(1 suppl):315-319.
Universitas Sumatera Utara
72
26. Bcl-2 protein in aggresive and non aggresive basal cell carcinoma, ( cited on
2014, juli 13). Available: www.ncbi.nlm.nih.gov/pubmed/10885404.
27. BCL-2
(B-cell
leukemia/lymphoma
2
.[cited2014,Juli20],available:
http://atlasgeneticsoncology.org/Genes/BCL-21D49.html.
28. An overview of Bcl-2 expression in histopatological variants of basal cell
carcinoma, squamous cell carcinoma, actinic keratosis, and seborrheic
keratosis.[cited2014,Juli20],available:www.ncbi.nlm.nih.
gov/pubmed/19138009
29. Hussain I, Sono M, Khan BS, Khan MD. Basal Cell Carcinoma Presentation:
Histopathological Features and Correlation with Clinical Behaviour [Internet];
2010 Jan: 3-7. [cited 2013 Aug 01]
30. Kumar, abbas, Fausto, Aster. Pathologic basis of Deases, 8Ed, Saunders, 2010.
31. Sanchez RL dan Raimer SS. Dermatopathology. Texas: Landes Bioscience,
Georgetown; 2001: p. 223-27.
32. Williams H, Bigby M, Diepgen T, Heirxheimer A, Naldi L, Rzany B. Evidencebased Dermatolog. London: BMJ Books; 2003: 324-43.
33. Wolff K, Allen RJ. Fitzpatrick's Color Atlas & Synopsis of Clinical
Dermatology. 6th ed. New York: McGraw-Hill Medical; 2009: p. 287-95.
34. Ko CJ, Barr RJ. Dermatopathology: Diagnosis by First Impression. UK:WileyBlackwell; 2011: 55-8. [cited 2013 Aug 01].
35. Rubin AI, Chen EH dan Ratner D. Basal-Cell Carcinoma. N Engl J Med; 2005:
2262-9. [cited 2013 Aug 01]
Universitas Sumatera Utara
73
36. Hoff DDV, Lorusso PM, Rudin CM, Reddy JC, Yauch RL, Tibes R, et al.
Inhibition of the Hedgehog Pathway in Advanced Basal-Cell Carcinoma. N Engl
J Med 2009; 361: 1164-1172. [cited 2013 Aug 01]
37. Epidermal
Growth
Factor
Receptor
[cited
2014,
Juli13]
Available:
Http://www.medicinenet.com.
38. Prognostic value of Ki-67, CD31 and epidermal
growth factor reseptor
ekspression in bacal cell carcinoma ( cited 2014, juli 13). Available:
http://online library. Wiley.com
39. Aneuploidy, but not Ki-67 or EGFR ekspression is associated with rekurences
in basal cell carcinoma. ( cited 2014, juli 13). Available: http://online library.
Wiley.com.
40. Targeted Therapy in Nonmelanoma skin cancer, ( cited on 2014, Juli 13), canc.
Available : www.mdpi.com/journal cancers
41. Wahyuni Sari Arlinda. Statistika kedokteran. Jakarta;2007.p.79-86.
42. Sastroasmoro Sudigdo, Ismael Sofian. Dasar-dasar metodologi penelitian
klinis.edisi 3.sagung seto;2010.p.78-88.
Universitas Sumatera Utara
DAFTAR PUSTAKA
1. Barhnhill RL, Croeson AN, Magro CM, Piepkorn MW. Dermatopathology. 3th
ed. New York:McGraw-Hill Medical; 2010: 578-590. [cited on 2013 Aug 01]
2.
Gawkrodger DJ. Dermatology: An Illustrated Colour Text. 3th ed. London:
Churchill Livingstone; 2002: 2,3,96,97. [cited on 2013 Aug 01]
3.
Tuzun Y, Kutlubay Z, Engin B, serdalogru S. Basal Cell Carcinoma. Turkey:
Istanbul University; 2011: 51-86. [cited 2014 Aug 01]
4.
UCSF Medical Centre. Basal cell and squamous cell carcinoma. San Fransisco;
2014 [cited 2014 Feb 03].
5. Weedon D, Marks R, Kao GF, Harwood CA. Keratinocytic tumours:
Introduction. In : LeBoit, PE, Burg G, Weedon D, Sarasin A. (editors).
Pathology and Genetics of Skin Tumours. World Health Organization
Classification of Tumour. Lyon: IARC Press; 2003: p.11-19.
6.
Flohil SC, Vries ED, Neumann M, Coeberg JW, Nijsten T. Incidence,
Prevalence and Future Trend of Primary Basal Cell Carcinoma in the
Netherland.Acta Derm Venereol.2011; 91: 24-30. [cited 2014 Feb 03]
7. Christenson LJ, Borrowman TA, Vachon CM, Tollefson MM, Otley GC,
Weaver AL, et al. Incidence of Basal Cell and Squamous Cell Carcinomas in a
Population Younger Than 40 Years.JAMA; 2005 Aug 9: 681-90. [cited 2014
Feb 03]
8. Cancer Council Australia. Clinical Practice Guide: Basal-Cell Carcinoma,
Squamous
Cell
Carcinoma
(and
related
lesion)-a
guide
to
clinical
Universitas Sumatera Utara
70
managementinAustralia.[Internet].2008Nov[cited2014Juli03];
http://www.cancer.org.au/content/pdf/HealthProfessionals/ClinicalGuidelines/B
asal_cell_carcinoma_Squamous_cell_carcinoma_Guide_Nov_2008Final_with_Corrigendums.pdf
9. Ricotti C, Bouzari N, Agadi A, Cockerell CJ. Malignant Skin Neoplasms. USA:
Elsevier Inc; 2009 : 1241- 54. [cited 2013 Aug 01]
10. Chinem VP, Miot HA. Epidemiology of Basal Cell Carcinoma. Anais
Brasileiros de Dermatologia. 2011; 86(2):292-305. [cited 2013 Aug 01]
11. Epstein EH. Basal cell carcinomas: Attack of the Hedgehog. USA; Mac Millan
Publisher Limited; 2008: 743-754. [cited 2013 Aug 01]
12. Gu D dan Xie J. Research progress in the cell origin of basal cell
carcinoma.World J Med Genet. Baishideng. 2011; 1(1):11-13. [cited 2013 Aug
01]
13. White GM, dan Cox NH. Malignant and Premalignant Epidermal Neoplasia. In:
Disease of the Skin. W.B. Saunders. USA.2002. [cited 2013 Aug 01]
14. Telfer NR, Colver GB dan Morton CA. Guidelines for the management of basal
carcinoma. British Journal of Dermatology 2008; 159: 35-48. [cited 2013 Aug
01]
15. Wu PA. The Epidemiology of Basal Cell Carcinomas.UpToDate, Inc.
[Internet]. 2014 [cited 2014Feb 03].
16. American Cancer Society. Skin Cancer: Basal and Squamous Cell. American
Cancer Society; 2012: 1-47. [cited 2013 Aug 01] Tersedia di website:
http://www.cancer.org/acs/groups/cid/documents/webcontent/003139-pdf.pdf
Universitas Sumatera Utara
71
17. The
Structure
and
Function
of
the
Skin.[cited
2013
Aug
01].
www.advancedbodyworks.co.uk/docs/skinEssay.pdf.
18. Turner R. Basal Cell Carcinoma. Oxford: Oxford Redcliffe Hospital NHS
Trust; 2011: 1-4. [cited 2014 Aug 01]
19. Oakley A dan Newman P. Cutaneus Tumours. DermNet NZ. New Zealand.
2012: 6. [cited 2014 Aug 01]
20. Hunter J, Savin J, Dahl M. Clinical Dermatology. 3th ed. Oxford: Blackwell
Science Ltd; 2002: 265-67. [cited 2014 Aug 01]
21. Buljan M, Bulat V,Situm M,Mihic LL, Duktaj SS. Variation in Clinical
Presentation of Basal Cell Carcinoma. Croatia: Acta Clin Croat; 2008: 25-30.
[cited 2014 Aug 01]
22. The Skin Cancer Foundation. Basal Cell Carcinoma-Causes and Risk Factors.
New
York.
2013
[cited
2013
Aug
01].
Tersedia
di
website:
http://www.skincancer.org/skin-cancer-information/basal-cell-carcinoma/bcccauses-and-risk-factors
23. Haskell H. Histology of the Skin. In: Busam KJ (editor). Dermatopathology.
USA: Saunders, an imprint of Elsevier Inc; 2010: p.1-4. [cited 2014 Aug 01]
24. Basal cell carcinoma : possible role of some proliferative and apoptotic factors (
cited on 2014,Agustus 12). J Egypt wom Dermatol sac. Vol 6 No.1.2009.
25. Immunohistochemical nuclear staining for p53, PCNA, Ki67, and Bcl-2 in
different histologic variants of basal cell carcinoma.( cited on 2014, Agustus
12), Rom J Morphol Embryonla 2011, 52(1 suppl):315-319.
Universitas Sumatera Utara
72
26. Bcl-2 protein in aggresive and non aggresive basal cell carcinoma, ( cited on
2014, juli 13). Available: www.ncbi.nlm.nih.gov/pubmed/10885404.
27. BCL-2
(B-cell
leukemia/lymphoma
2
.[cited2014,Juli20],available:
http://atlasgeneticsoncology.org/Genes/BCL-21D49.html.
28. An overview of Bcl-2 expression in histopatological variants of basal cell
carcinoma, squamous cell carcinoma, actinic keratosis, and seborrheic
keratosis.[cited2014,Juli20],available:www.ncbi.nlm.nih.
gov/pubmed/19138009
29. Hussain I, Sono M, Khan BS, Khan MD. Basal Cell Carcinoma Presentation:
Histopathological Features and Correlation with Clinical Behaviour [Internet];
2010 Jan: 3-7. [cited 2013 Aug 01]
30. Kumar, abbas, Fausto, Aster. Pathologic basis of Deases, 8Ed, Saunders, 2010.
31. Sanchez RL dan Raimer SS. Dermatopathology. Texas: Landes Bioscience,
Georgetown; 2001: p. 223-27.
32. Williams H, Bigby M, Diepgen T, Heirxheimer A, Naldi L, Rzany B. Evidencebased Dermatolog. London: BMJ Books; 2003: 324-43.
33. Wolff K, Allen RJ. Fitzpatrick's Color Atlas & Synopsis of Clinical
Dermatology. 6th ed. New York: McGraw-Hill Medical; 2009: p. 287-95.
34. Ko CJ, Barr RJ. Dermatopathology: Diagnosis by First Impression. UK:WileyBlackwell; 2011: 55-8. [cited 2013 Aug 01].
35. Rubin AI, Chen EH dan Ratner D. Basal-Cell Carcinoma. N Engl J Med; 2005:
2262-9. [cited 2013 Aug 01]
Universitas Sumatera Utara
73
36. Hoff DDV, Lorusso PM, Rudin CM, Reddy JC, Yauch RL, Tibes R, et al.
Inhibition of the Hedgehog Pathway in Advanced Basal-Cell Carcinoma. N Engl
J Med 2009; 361: 1164-1172. [cited 2013 Aug 01]
37. Epidermal
Growth
Factor
Receptor
[cited
2014,
Juli13]
Available:
Http://www.medicinenet.com.
38. Prognostic value of Ki-67, CD31 and epidermal
growth factor reseptor
ekspression in bacal cell carcinoma ( cited 2014, juli 13). Available:
http://online library. Wiley.com
39. Aneuploidy, but not Ki-67 or EGFR ekspression is associated with rekurences
in basal cell carcinoma. ( cited 2014, juli 13). Available: http://online library.
Wiley.com.
40. Targeted Therapy in Nonmelanoma skin cancer, ( cited on 2014, Juli 13), canc.
Available : www.mdpi.com/journal cancers
41. Wahyuni Sari Arlinda. Statistika kedokteran. Jakarta;2007.p.79-86.
42. Sastroasmoro Sudigdo, Ismael Sofian. Dasar-dasar metodologi penelitian
klinis.edisi 3.sagung seto;2010.p.78-88.
Universitas Sumatera Utara